Seagen Inc.(NASDAQ : SGEN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||3.42%||10.88||0.7%||$760.55m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.71%||198.14||1.9%||$407.65m|
|GILD||Gilead Sciences, Inc.||0.03%||68.31||1.0%||$401.42m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.45%||577.19||2.7%||$355.48m|
|NTLA||Intellia Therapeutics, Inc.||-2.47%||138.35||2.3%||$257.39m|
|CRSP||CRISPR Therapeutics AG||1.72%||123.10||0.6%||$147.21m|
|XBIO||Xenetic Biosciences, Inc.||24.82%||5.08||0.0%||$127.54m|
|EXAS||EXACT Sciences Corp.||1.66%||109.63||18.1%||$125.64m|
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.